NASDAQ:TXG | Key Financial Ratios | 10x Genomics, Inc.

Complete source-backed ratio history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-305.69-7.29%-9.10%
2026-03-315.9-2.23%-2.78%
2025-12-314.46-4.18%-5.47%
2025-09-304.48-7.43%-9.72%
2025-06-305.84-8.63%-10.94%
2025-03-315.37-17.38%-22.21%
2024-12-314.97-19.88%-25.72%
2024-09-304.9-19.47%-25.26%
2024-06-305.22-25.79%-33.12%
2024-03-315.22-28.64%-36.77%
2023-12-314.69-26.43%-34.42%
2023-09-305.37-23.55%-29.97%
2023-06-305.94-17.41%-21.72%
2023-03-315.37-17.19%-21.73%
2022-12-314.85-16.13%-20.60%
2022-09-304.96-16.79%-21.56%
2022-06-305.65-14.23%-18.19%
2022-03-317.38-8.88%-11.04%
2021-12-316.77-5.71%-7.12%
2021-09-307.41-45.97%-56.90%
2021-06-306.69-51.56%-64.24%
2021-03-316.19-55.88%-70.85%
2020-12-316.560-58.40%-73.43%
2020-09-306.190-12.88%-16.28%
2020-06-303.70-13.39%-19.95%
2020-03-317.28-7.99%-11.92%
2019-12-317.630.07-5.16%-7.44%
2019-09-309.830.07-17.39%-23.64%
2019-06-3046.23%
2019-03-3145.38%
2018-12-313.28-0.13-90.49%51.13%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-314.46-4.18%-5.47%
2024-12-314.97-19.88%-25.72%
2023-12-314.69-26.43%-34.42%
2022-12-314.85-16.13%-20.60%
2021-12-316.77-5.71%-7.12%
2020-12-316.560-58.40%-73.43%
2019-12-317.630.07-5.16%-7.44%
2018-12-313.28-0.13-90.49%51.13%
2017-12-3116.68%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.